HomeFDMT • NASDAQ
add
4D Molecular Therapeutics Inc
Previous close
$9.97
Day range
$9.25 - $9.96
Year range
$9.25 - $36.25
Market cap
480.72M USD
Avg Volume
902.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 5.00K | -97.91% |
Operating expense | 10.60M | 20.59% |
Net income | -34.95M | -18.02% |
Net profit margin | -699.06K | -5,541.39% |
Earnings per share | -0.63 | 18.18% |
EBITDA | -41.26M | -32.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 541.95M | 74.63% |
Total assets | 620.12M | 75.92% |
Total liabilities | 31.78M | 16.15% |
Total equity | 588.34M | — |
Shares outstanding | 51.97M | — |
Price to book | 0.88 | — |
Return on assets | -16.98% | — |
Return on capital | -17.45% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -34.95M | -18.02% |
Cash from operations | -30.24M | -37.06% |
Cash from investing | -73.54M | -249.20% |
Cash from financing | 17.25M | -86.78% |
Net change in cash | -86.53M | -154.86% |
Free cash flow | -17.22M | -29.52% |
About
Founded
2013
Headquarters
Website
Employees
201